The Massachusetts governor is going to have a tough year in the spotlight on stem cells, as Harvard & co. press for state funding and boundless freedom, as this piece in the Globe today reminds. If Romney does it right, Massachusetts will set an important precedent. (Of course, the reverse is just as true.)